Study - Selective laser sintering 3D printing

Selective Laser Sintering 3D Printing of Orally Disintegrating Printlets Containing Ondansetron

Losan Pharma and FabRx have demonstrated the potential of selective laser sintering 3D printing to fabricate orodispersible printlets with characteristics similar to a commercial orally disintegrating tablet, but with the added benefit of using a manufacturing technology able to prepare medicines individualized to the patient.

The study was published in Pharmaceutics 2020, 12, 110.